Janus Henderson Mid Cap Value Fund (JMVAX)
Defensive Mid-Cap Value Equities


Fund Facts (JMVAX)
Inception Date8/12/1998
Total Net Assets (As of 7/31/18)$3.79B
Total Number of Equity Issues
(As of 7/31/18)
Weighted Average Market Capitalization ($ billion)
(As of 7/31/18)
Median Market
Capitalization ($ billion)
(As of 7/31/18)
Annual Expense Ratios
(As of fiscal year end 6/30/17)
GROSS 0.61%
NET 0.61%
PERFORMANCE (As of 6/30/18)
1 Year7.45%
3 Year9.54%
5 Year9.64%
10 Year7.98%
MORNINGSTAR (As of 7/31/18)
CategoryUS Fund Mid-Cap Value
Overall Rating™
(Based on risk-adjusted returns)
371 Funds Rated
View all Ratings
Analyst Rating
Style Box

Important Morningstar Information

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Defensive Mid-Cap Value

Defensive Mid-Cap Value Equities

Diversified portfolios of what we believe are high-quality, undervalued stocks

Disciplined valuation process measures downside risk before upside potential


Kevin Preloger

Kevin Preloger

Fund Manager since 2013
Industry since 1997

Justin Tugman

Justin Tugman, CFA

Fund Manager since 2015
Industry since 2000